Effects of cognitive behavioural therapy and return-to-work intervention for patients on sick leave due to stress-related disorders: Results from a randomized trial.
Sigrid SalomonssonFredrik SantoftElin LindsäterKersti EjebyMartin IngvarBrjánn LjótssonLars-Göran ÖstMats LekanderErik Hedman-LagerlöfPublished in: Scandinavian journal of psychology (2019)
The aim of this study was to evaluate specific effects for patients with adjustment or exhaustion disorder, the Stress subgroup (n = 152), regarding symptom severity and sick leave after CBT, a return-to-work intervention (RTW-I), and a combination of them (COMBO), using data from a randomized trial. In the original study, primary care patients on sick leave (N = 211) were randomized to CBT (n = 64), RTW-I (n = 67), or COMBO (n = 80). Blinded Clinician Severity Rating (CSR) of symptoms and sick leave registry data were primary outcomes. Subgroup analyses showed that for the Stress subgroup, CBT led to greater reduction of symptoms than RTW-I posttreatment, but COMBO did not differ from CBT or RTW-I. Regarding sick leave, there was no difference between treatments in the Stress subgroup. An exploratory analysis of the treatment effects in a subgroup of patients with depression, anxiety or insomnia indicates that RTW-I reduced sick leave faster than CBT. We conclude that CBT may be promising as an effective treatment of stress and exhaustion disorder.
Keyphrases
- end stage renal disease
- primary care
- phase iii
- newly diagnosed
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- sleep quality
- depressive symptoms
- stress induced
- peritoneal dialysis
- open label
- stem cells
- electronic health record
- prognostic factors
- patient reported outcomes
- clinical trial
- double blind
- physical activity
- skeletal muscle
- insulin resistance
- combination therapy
- placebo controlled
- study protocol
- phase ii
- general practice